Virucidal polymers serve as effective antivirals by not only inhibiting viruses but also destroying them. Inspired by the chemical properties of mucin‐mimetics, dendronized polyglycerol‐sulfated, mucin‐inspired amphiphilic copolymers (MIACPs) have been developed.
Raju Bej +10 more
wiley +1 more source
A two-dose viral-vectored Plasmodium vivax multistage vaccine confers durable protection and transmission-blockade in a pre-clinical study [PDF]
Yutaro Yamamoto +12 more
openalex +1 more source
Genome‐wide codon reprogramming of influenza A virus introduces 1956 synonymous mutations across five segments and elevates CpG content, causing defective NA packaging, loss of NS1 accumulation, and enhanced ZAP‐mediated antiviral responses without affecting RNA or protein synthesis. These mechanisms result in profound attenuation and potent homologous
Yang Wang +13 more
wiley +1 more source
Natural an dartificial protein cages : design, structure and therapeutic applications [PDF]
Chakraborti, Soumyananda +2 more
core +1 more source
Does modified-live viral vaccine administration to heifers or cows lack substantial risk?
M. Daniel Givens, Benjamin W. Newcomer
openalex +1 more source
Epidemiology of respiratory viral infections in children enrolled in a study of influenza vaccine effectiveness [PDF]
Alexa Dierig +9 more
openalex +1 more source
Bivalent therapeutic vaccine against HPV16/18 genotypes consisting of a fusion protein between the extra domain A from human fibronectin and HPV16/18 E7 viral antigens [PDF]
Laura Arribillaga +15 more
openalex +1 more source
GPCRs in CAR‐T Cell Immunotherapy: Expanding the Target Landscape and Enhancing Therapeutic Efficacy
Chimeric antigen receptor T cell therapy faces dual challenges of target scarcity and an immunosuppressive microenvironment in solid tumors. This review highlights how G protein‐coupled receptors can serve as both novel targets to expand the therapeutic scope and functional modules to enhance CAR‐T cell efficacy.
Zhuoqun Liu +11 more
wiley +1 more source
Problems of vaccine developmet using influenza viral proteins or plasmid DNAs encoding the proteins.
Shin-ichi Tamura
openalex +2 more sources

